Among the causes of thrombocytosis is the capability of some tumor cells to produce thrombopoietin, and an upregulation of the platelet activation markers, such as P-selectin, β-thrombomodulin, or CD40 ligand, contributing to an increase in the platelet count [21]. This evidence concerns the gene SELP and thrombocytosis disease.